PHILADELPHIA –Sara Aton, PhD, Postdoctoral Fellow in the Department of Neuroscience at the University of Pennsylvania School of Medicine, was awarded a grant from the L’Oréal USA For Women in Science Program. Laurent Attal, President and CEO, L’Oréal USA, and Dr. Ralph J. Cicerone, President, National Academy of Sciences, honored Dr. Aton, along with the other five 2008 recipients at the American Museum of Natural History in New York City. This prestigious fellowship provides support to postdoctoral women who are undertaking cutting-edge research with practical applications.
Dr. Sara Aton: A Day in the Lab
Click on thumbnail
to view full-size image
“I was surprised and delighted when I found out that I had been selected for the L'Oreal award,” said Dr. Aton. “The work of this year’s fellows has real potential to change our world. So to say I am honored to have been placed among them is an understatement.”
The L’Oréal USA Fellowship program started in 2003 and each year identifies and rewards five female, postdoctoral researchers with grants. Starting in 2007, the grants doubled in value from $20,000 to $40,000.
Dr. Aton will use this grant to study a key biological component underlying learning and memory called synaptic plasticity. She studies the role of connections between nerve cells in consolidating ocular dominance plasticity during sleep by recording large groups of individual neurons in freely sleeping animals. Ocular dominance plasticity is a term that describes the remodeling of nerve synapses that occurs in the visual cortex of the brain in response to changes in visual input from both eyes.
“Because sleep seems to also be involved in learning and memory consolidation, we use ocular dominance plasticity as a system to probe the general mechanisms by which sleep may facilitate learning and memory,” she explains.
This will be the first study attempting such large-scale recording of neurons within a synaptically-integrated network during plastic remodeling. Dr. Aton adds, “The L'Oreal For Women in Science Fellowship will allow me to purchase the equipment required to address this issue.”
The results of this research will lay the foundation for continued study of how sleep affects cognition and how sleep deprivation adversely affects neural function. “The data we will be able to collect from this experiment may lead to major breakthroughs in our understanding of what goes on in the brain during sleep, how it differs from activity during waking, and what these differences mean for brain function,” comments Dr. Aton.
This research may reveal implications and possible solutions for those who are confined to restricted sleep schedules. The long-term goal of Dr. Aton’s research is to clarify how sleep contributes to learning and memory.
Dr. Aton received her B.S. in Biopsychology & Cognitive Science from the University of Michigan and her Ph.D. in Neuroscience from Washington University in St. Louis in 2006. She was a recipient of the National Science Foundation graduate research fellowship, National Research Service Awards from the National Institute of Mental Health and National Eye Institute, and a postdoctoral fellowship from the National Sleep Foundation.
PENN Medicine is a $3.5 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.
Penn's School of Medicine is currently ranked #4 in the nation in U.S.News & World Report's survey of top research-oriented medical schools; and, according to most recent data from the National Institutes of Health, received over $379 million in NIH research funds in the 2006 fiscal year. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System includes three hospitals — its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation’s “Honor Roll” hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center — a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.